Today in Healthcare
SEE OTHER BRANDS

Fresh news on healthcare in the world

Today in Healthcare: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.

Press releases published on September 7, 2025

KFSHRC to Partake Tomorrow as Strategic Partner in C3 Davos of Healthcare™ New York Summit

KFSHRC to Partake Tomorrow as Strategic Partner in C3 Davos of Healthcare™ New York Summit

RIYADH, SAUDI ARABIA, September 7, 2025 /⁨EINPresswire.com⁩/ -- King Faisal Specialist Hospital …

Smart Tech, Human Touch: Diane Tomb Calls for Balance Between AI Innovation and the Doctor–Patient Relationship

Smart Tech, Human Touch: Diane Tomb Calls for Balance Between AI Innovation and the Doctor–Patient Relationship

Tomb and Associates Advisory Draws from Personal Experience Urging Policymakers to Protect Human Connection in Healthcare While Embracing Technological Advances WASHINGTON, DC, UNITED STATES, September 7, 2025 /⁨EINPresswire.com⁩/ -- Diane Tomb, founder …

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis

NEW YORK and WALTHAM, Mass., Sept. 07, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune …

KFSHRC to Partake Tomorrow as Strategic Partner in C3 Davos of Healthcare™ New York Summit

KFSHRC to Partake Tomorrow as Strategic Partner in C3 Davos of Healthcare™ New York Summit

NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital …

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …

Un estudio sobre la genética del cáncer de pulmón lanza una plataforma de datos de código abierto para la comunidad investigadora

Un estudio sobre la genética del cáncer de pulmón lanza una plataforma de datos de código abierto para la comunidad investigadora

SAN FRANCISCO, Sept. 07, 2025 (GLOBE NEWSWIRE) -- El Instituto de Investigación 23andMe, Troper Wojcicki Philanthropies (TWP) y Lifebit han anunciado hoy el lanzamiento oficial de una plataforma de datos de código abierto para el Estudio genético sobre el …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions